(VSCP) (VSCP) Stock Price, News & Analysis

Company Overview

VirtualScopics, Inc. is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable reproducible measurement of minute changes that occur in anatomic structures in oncology, cardiology, neurology and musculoskeletal diseases. It has developed a system which enables the assessment of oncology patients per standard Response Evaluation Criteria in Solid Tumors criteria, while permitting the measurement of measures, including tumor volume, tumor metabolic rate through fluorodeoxyglucose-positron emission tomography and tumor mitotic rate through fluorodeoxyglucose-positron emission tomography or tumor cellular density through diffusion magnetic resonance imaging.

Key Stats

• Today's Range: $4.04 to $4.04
• 50-Day Range: N/A
• 52-Week Range: $1.73 to $6.65
• Volume: N/A
• Average Volume: 34,573 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VSCP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (VSCP) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (VSCP) investors own include InterCloud Systems (ICLD), Acer Therapeutics (ACER), Novavax (NVAX), SELLAS Life Sciences Group (SLS), (UNISQ) (UNISQ) and Amarin (AMRN).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:VSCP
• CUSIP: N/A
• CIK: 1307752
• Web: www.virtualscopics.com
• Phone: +1-585-2496231
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A